贝伐珠单抗应用于非小细胞肺癌中的研究进展(4)
[7] Chen JH,Yang JL, Chou CY, et al. Indirect comparison of efficacy and safety between immune checkpoint inhibitors and antiangiogenic therapy in advanced non-small-cell lung cancer[J]. Sci Rep,2018,8(1):9686.[8] Reck M,Garassino MC,Imbimbo M,et al. Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting[J]. Lung Cancer ......
您现在查看是摘要页,全文长 2545 字符。